Douglas A Treco insider trades

Open-market stock purchases and sales by Douglas A Treco, Unknown at CRISPR Therapeutics AG, from SEC Form 4 filings since Feb 1, 2017.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -11%.

Recent trades

DateStockTradeValue
Jun 5, 2026CRSP CRISPR Therapeutics AGBought (not open market)—

Companies traded

  • CRSP CRISPR Therapeutics AG: 1 buy, last Jun 5, 2026
  • INZY Inozyme Pharma, Inc: 2 sales, last Jul 1, 2025
  • RARX Ra Pharmaceuticals, Inc: other filings, last Apr 2, 2020

Get free alerts when Douglas A Treco files a new trade →